2-Bromo-[1,2,4]triazolo[1,5-a]pyridin-6-amine, 100mg

1-(4,4-DIFLUOROCYCLOHEXYL)ETHANONE, 95.0%, 500mg

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 500 ml, 19/26, 2 Unidad(es)

1-(diazyn-1-ium-1-yl)-18-hydroxy-4,7,10,13,16-pentaoxa-1-azaoctadecan-1-ide, 98%, 250mg

Ethyl 5-Nitrobenzofuran-2-carboxylate>97.0%(GC)5g

4-BROMO-6-METHOXYISOQUINOLINE, 95%, 100mg

8-Bromo-6-chloro-2-methyl-[1,2,4]triazolo[1,5-a]pyridine, 95.0%, 1g

Ethyl 3-methoxy-4-methylbenzoate, 98%, 5g

3-(2-Aminoethoxy)pyridine, 95.0%, 5g

5-[(4-tert-butylphenoxy)methyl]-4-methyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

Columna capilar GC ROTI®Cap-1 MS, 25 m, 0,20 mm, 0,20 µm, 1 Pieza(s)

2-(3-((2-BROMOPHENOXY)METHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 1g

2-Bromo-4-fluorobenzaldehyde, 98.0%, 500g